DOCSLIB.ORG

Lncrna BC200 Regulates the Cell Proliferation and Cisplatin Resistance in Non-Small Cell Lung Cancer Via PI3K/AKT Pathway

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lncrna BC200 Regulates the Cell Proliferation and Cisplatin Resistance in Non-Small Cell Lung Cancer Via PI3K/AKT Pathway European Review for Medical and Pharmacological Sciences 2019; 23: 1093-1101 LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway B.-B. GAO, S.-X. WANG Cancer Treatment Center, Shandong Provincial Hospital Affiliated to Shandong University, Ji’nan, China. Abstract. – OBJECTIVE: Long non-coding mor stage and metastasis of NSCLC patients. RNA (lncRNA) exerts tissue specificity and reg- BC200 promotes the malignant progression of ulates the occurrence and progression of tu- NSCLC via regulating cisplatin-induced apopto- mors. Previous bioinformatics showed that sis of H1299/DDP cells. lncRNA BC200 is served as an oncogene. How- ever, the specific role of BC200 in lung cancer Key Words: (LC) is rarely reported. The aim of this study is BC200, NSCLC, Cisplatin resistance, Malignant pro- to elucidate the regulatory effects of BC200 on gression. tumor development and cisplatin resistance in non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: The expression Introduction level of BC200 in 76 pairs of NSCLC tissues and adjacent normal tissues was detected by quan- titative Real Time-Polymerase Chain Reaction Lung cancer (LC) is a common primary tumor (qRT-PCR). Correlation analyses were conduct- of the respiratory system, which is the leading ma- ed to investigate the relation between BC200 ex- lignancy throughout the world1,2. Non-small cell pression and prognosis of NSCLC patients. Sub- lung cancer (NSCLC) is the most common type sequently, BC200 expression in LC cell lines was of LC, accounting for about 80% of LC cases. detected. After construction of si-BC200 and si- According to the pathological types, NSCLC is NC, the cellular functions of LC cells were de- divided into squamous cell carcinoma, adenocar- tected through colony formation, flow cytometry 3,4 and transwell assay, respectively. Western blot cinoma and large cell carcinoma . About 75% of was performed to detect the protein expressions NSCLC patients are already in an advanced stage of key genes in the PI3K/AKT pathway in LC of diagnosis, leading to the low 5-year survival cells. Finally, cell counting kit-8 (CCK-8) assay rate3,4. Genetics factors, diet, unhealthy lifestyles was carried out to explore the effect of BC200 and precancerous lesions are all closely related to on cisplatin resistance of LC cells via calculat- ing IC50. NSCLC occurrence. It is reported that over 50% RESULTS: Higher expression of BC200 was of NSCLC patients experience micrometastasis found in NSCLC tissues than that of adjacent before radical surgery, which is the direct cau- normal tissues. BC200 expression was positive- se of postoperative metastasis and recurrence3-6. ly correlated with tumor stage, lymph node me- The comprehensive understanding of the molecu- tastasis and distant metastasis of NSCLC pa- lar mechanism of NSCLC contributes to develop tients, whereas not correlated to age and sex. effective therapeutic approaches and to improve Knockdown of BC200 inhibited proliferation, in- vasion and migration of LC cells. Western blot the clinical outcomes of affected people. Cur- results showed that protein expressions of PI3K, rently, surgical resection and chemotherapy are AKT and STAT3 were downregulated after BC200 the preferred options for treating NSCLC, which knockdown in LC cells. Additionally, the IC50 in can greatly prevent recurrence and metastasis of H1299/DDP cells transfected with si-BC200 was NSCLC. However, chemotherapy resistance is lower than in those transfected with si-NC. The the main cause of chemotherapy failure, remar- apoptotic rate in H1299 cells transfected with si- 5,6 BC200 was remarkably lower than those trans- kably limiting its clinical application . With the fected with si-NC. in-depth researches on NSCLC, it is believed that CONCLUSIONS: BC200 is highly expressed NSCLC is the result of genetic and environmen- in NSCLC, which is positively correlated with tu- tal factors. Alterations in certain oncogenes and Corresponding Author: Shengxi Wang, MD; e-mail: [email protected] 1093 B.-B. Gao, S.-X. Wang tumor-suppressor genes finally lead to disordered Patients and Methods cell proliferation, apoptosis and differentiation7,8. Non-coding RNAs have been well recognized in Sample Collection recent years. Among them, long non-coding RNA 76 pairs of NSCLC tissues and adjacent normal (lncRNA) is a kind of non-coding RNA with over tissues were surgically resected. Enrolled patients 200 bases in length9-11. LncRNAs may be differen- were all pathologically diagnosed as NSCLC and tially expressed in malignancies, which are closely received DDP (cisplatin) chemotherapy (Table I). related to the progression of tumors. Certain lncR- Based on the therapeutic outcomes of DDP che- NAs could be served as diagnostic and prognostic motherapy, patients were divided into DDP-sen- markers12,13. Functionally, lncRNA degrades or sitive group (n=31) and DDP-insensitive group inhibits the target mRNA, thereafter regulating (n=45). This study was approved by the Shandong target gene expressions14,15. Misexpression of ln- Provincial Hospital Affiliated to Shandong Uni- cRNA may result in multiple misexpressed pro- versity Ethics Committee and all patients signed teins14,15. Accumulating evidence has shown that the informed consent. lncRNAs are closely related to the occurrence and progression of malignancies, which are served as Cell Culture tumor hallmarks16. For example, lncRNA BC200 Human LC cell lines (SKMES1, A549, PC- is differentially expressed in tumors and is utilized 9, H358, H1299 and SPCA1) and human bron- as a biomarker17-19. Our previous studies20,21 have chial epithelial cell line (16HBE) were obtained already found that BC200 is highly expressed in from Cell Bank, Chinese Academy of Sciences. NSCLC as an oncogene, which promotes prolife- DDP-resistance H1299 cells (H1299/DDP) were ration and induces apoptosis of LC cells. However, obtained from Runcheng (Shanghai, China). Cel- the potential mechanism of BC200 in regulating ls were cultured in Dulbecco’s Modified Eagle NSCLC development has not been fully elucida- Medium (DMEM; Gibco, Rockville, MD, USA) ted. Through literature review22,23, we concluded containing 10% fetal bovine serum (FBS; Gibco, that BC200 is involved in regulating proliferation, Rockville, MD, USA) and maintained in a 5% apoptosis, differentiation and metastasis of tumor CO2 incubator at 37°C. cells. The specific role of BC200 in NSCLC still needs to be further investigated. Transfection In the present work, we first detected the H1299 and H1299/DDP cells in logarithmic expression level of BC200 in NSCLC tissues and growth phase were seeded in the 6-well plates at adjacent normal tissues. The regulatory effect of a density of 5×104 cells per well. Cells were tran- BC200 on cisplatin resistance of LC cells and sfected with si-BC200 or si-NC according to the NSCLC tissues were further explored. instructions of Lipofectamine 2000 (Invitrogen, Table I. Association of lncRNA BC200 expression with clinicopathologic characteristics of non-small cell lung cancer. lncRNA BC200 expression Parameters Number of cases Low High p-value Age (years) 0.488 <60 32 20 12 ≥60 44 24 20 Gender 0.096 Male 37 25 12 Female 39 19 20 T stage 0.017 T1-T2 43 30 13 T3-T4 33 14 19 Lymph node metastasis 0.019 No 45 31 14 Yes 31 13 18 Distance metastasis 0.010 No 60 40 20 Yes 16 4 12 1094 LncRNA BC200 and cisplatin resistance in non-small cell lung cancer Carlsbad, CA, USA). Culture medium was repla- Deoxyribose Nucleic Acid (cDNA). The sequen- ced 5-6 hours later. ce of specific BC200 RT primers was 5′-AGAC- CTGCCTGGGCAATATAGC-3′, glyceraldehy- Cell Proliferation Assay de 3-phosphate dehydrogenase (GAPDH) was Transfected cells were digested for the prepara- 5′-CATGAGAAGTATGACAACAGCCT-3′. tion of cell suspension (5×104/mL). 100 μL of the The sequences of specific BC200 PCR primers: suspension was added in each well of the 96-well forward, 5′-AGACCTGCCTGGGCAATATA- plates. 24 hours after cell adherence, 100 μL of GC-3′ and reverse, 5′-GTTGTTGCTTTGAGG- medium containing 0, 1, 2, 4, 8, 16, 32, and 64 μg/ GAAGTTACG-3′. The expression levels of BC200 mL DDP was added. Each concentration had 5 were normalized to GAPDH (forward, 5′-CAT- replicates. After cell culture for 48 h, 10 μL of cell GAGAAGTATGACAACAGCCT-3′ and reverse, counting kit-8 (CCK-8) solution (Dojindo, Kuma- 5′-AGTCCTTCCACGATACCAAAGT-3′). After moto, Japan) was added and the optical density the cDNA was amplified, qRT-PCR was perfor- was determined at the wavelength of 450 nm 1 med to detect the expressions of related genes. hour later. The IC50 was finally calculated. Western Blot Colony Formation Assay Cells were lysed for protein extraction. The 200 transfected cells were seeded in each well concentration of each protein sample was deter- of the 6-well plates for 2-week cell culture. The mined by a BCA (bicinchoninic acid) kit (Abcam, medium was replaced once a week. Cells were Cambridge, MA, USA). The protein sample was then washed with phosphate-buffered saline separated by gel electrophoresis and transferred (PBS), fixed with methanol for 20 min and stained to PVDF (polyvinylidene difluoride) membranes with 0.1% crystal violet for 20 min. Colonies were (Millipore, Billerica, MA, USA). After incuba- captured using a microscope. tion with the primary and secondary antibody (Cell Signaling Technology, Danvers, MA, USA), Flow Cytometry Analysis of Cell Apoptosis immunoreactive bands were exposed by enhan- H1299 and SPCA1 cells in logarithmic growth ced chemiluminescence method (ECL). phase were seeded in the 6-well plates. After transfection for 24 h, cells were centrifuged and Statistical Analysis resuspended in 500 μL of Binding Buffer. Sub- We used Statistical Product and Service Solu- sequently, cells were incubated with 5 μL of An- tions (SPSS) 22.0 software (IBM, Armonk, NY, nexin V-APC and 5 μL of 7-AAD in the dark for USA) for statistical analysis.
Load more

Recommended publications
  • Mechanistic Involvement of Long Non-Coding Rnas in Oncotherapeutics Resistance in Triple-Negative Breast Cancer
    cells Review Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer Samarth Kansara 1, Vijay Pandey 2,3, Peter E. Lobie 2,3, Gautam Sethi 4,*, Manoj Garg 5 and Amit Kumar Pandey 1,* 1 Amity Institute of Biotechnology, Amity University Haryana, Panchgaon, Manesar, Haryana 122413, India; [email protected] 2 Tsinghua-Berkeley Shenzhen Institute, Tsinghua University, Shenzhen 518005, China; [email protected] (V.P.); [email protected] (P.E.L.) 3 Shenzhen Bay Laboratory, Shenzhen 518055, China 4 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore 5 Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University, Sector-125, Noida 201313, India; [email protected] * Correspondence: [email protected] (G.S.); [email protected] (A.K.P.) Received: 28 May 2020; Accepted: 19 June 2020; Published: 21 June 2020 Abstract: Triple-negative breast cancer (TNBC) is one of the most lethal forms of breast cancer (BC), with a significant disease burden worldwide. Chemoresistance and lack of targeted therapeutics are major hindrances to effective treatments in the clinic and are crucial causes of a worse prognosis and high rate of relapse/recurrence in patients diagnosed with TNBC. In the last decade, long non-coding RNAs (lncRNAs) have been found to perform a pivotal role in most cellular functions. The aberrant functional expression of lncRNAs plays an ever-increasing role in the progression of diverse malignancies, including TNBC. Therefore, lncRNAs have been recently studied as predictors and modifiers of chemoresistance.
    [Show full text]
  • Thyroid Hormone Negatively Regulates Tumorigenesis Through Suppression of BC200
    25 12 Endocrine-Related Y-H Lin et al. BC200 is an oncogenic driver 25:12 967–979 Cancer in HCC RESEARCH Thyroid hormone negatively regulates tumorigenesis through suppression of BC200 Yang-Hsiang Lin1,2, Meng-Han Wu1, Ya-Hui Huang2, Chau-Ting Yeh2, Hsiang-Cheng Chi1,3, Chung-Ying Tsai4, Wen-Yu Chuang5, Chia-Jung Yu6,7,8,9, I-Hsiao Chung1, Ching-Ying Chen1 and Kwang-Huei Lin1,2,7,10 1Department of Biochemistry, College of Medicine, Chang Gung University, Taoyuan, Taiwan 2Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan 3Radiation Biology Research Center, Institute for Radiological Research, Chang Gung University/Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan 4Kidney Research Center and Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan, Taiwan 5Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan 6Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan 7Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan 8Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan 9Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan 10Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, Taiwan Correspondence should be addressed to K-H Lin: [email protected] Abstract Thyroid hormone (T3) and its receptor (TR) are involved in cancer progression. While Key Words deregulation of long non-coding RNA (lncRNA) expression has been detected in f thyroid hormone many tumor types, the mechanisms underlying specific involvement of lncRNAs in f non-coding RNA tumorigenicity remain unclear.
    [Show full text]
  • Molecular Functions and Clinical Impact of Thyroid Hormone-Triggered Autophagy in Liver-Related Diseases
    Chi et al. Journal of Biomedical Science (2019) 26:24 https://doi.org/10.1186/s12929-019-0517-x REVIEW Open Access Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases Hsiang-Cheng Chi1†, Chung-Ying Tsai2†, Ming-Ming Tsai3,4,7, Chau-Ting Yeh5 and Kwang-Huei Lin5,6,7* Abstract The liver is controlled by several metabolic hormones, including thyroid hormone, and characteristically displays high lysosomal activity as well as metabolic stress-triggered autophagy, which is stringently regulated by the levels of hormones and metabolites. Hepatic autophagy provides energy through catabolism of glucose, amino acids and free fatty acids for starved cells, facilitating the generation of new macromolecules and maintenance of the quantity and quality of cellular organelles, such as mitochondria. Dysregulation of autophagy and defective mitochondrial homeostasis contribute to hepatocyte injury and liver-related diseases, such as non-alcoholic fatty liver disease (NAFLD) and liver cancer. Thyroid hormones (TH) mediate several critical physiological processes including organ development, cell differentiation, metabolism and cell growth and maintenance. Accumulating evidence has revealed dysregulation of cellular TH activity as the underlying cause of several liver-related diseases, including alcoholic or non-alcoholic fatty liver disease and liver cancer. Data from epidemiologic, animal and clinical studies collectively support preventive functions of THs in liver-related diseases, highlighting the therapeutic potential of TH analogs. Elucidation of the molecular mechanisms and downstream targets of TH should thus facilitate the development of therapeutic strategies for a number of major public health issues. Here, we have reviewed recent studies focusing on the involvement of THs in hepatic homeostasis through induction of autophagy and their implications in liver-related diseases.
    [Show full text]
  • BCYRN1 Is Correlated with Progression and Prognosis in Gastric Cancer
    Bioscience Reports (2019) 39 BSR20190505 https://doi.org/10.1042/BSR20190505 Research Article BCYRN1 is correlated with progression and prognosis in gastric cancer Hongbing Zhai1 and Yanju Li2 1Department of Gastroenterology, Xianyang Central Hospital, Xianyang 712000, Shaanxi, China; 2Department of Pathology, Yanan University Affiliated Hospital, Yan’an 716000, Shaanxi, China Downloaded from http://portlandpress.com/bioscirep/article-pdf/39/11/BSR20190505/860279/bsr-2019-0505.pdf by guest on 23 September 2021 Correspondence: Yanju Li ([email protected]) Long non-coding RNA brain cytoplasmic RNA 1 (BCYRN1) has been found to play an im- portant role in tumorigenesis of a variety of tumors including gastric cancer (GC). However, the prognostic significance and molecular mechanism of BCYRN1 was still unknown inGC. In the present study, we found BCYRN1 expression was dramatically elevated in GC tis- sues and cell lines, and positively associated with tumor depth, lymph node metastasis and clinical stage in patients with GC. Moreover, univariate and multivariate Cox regression analyses demonstrated that high BCYRN1 expression was independent prognostic factor for overall survival in GC patients. In lncRNA-microRNA interactome database, we found that there were putative binding sites between BCYRN1 and miR-204-5p. Furthermore, we confirmed that down-regulation of BCYRN1 inhibited GC cell proliferation, migration andin- vasion through directly up-regulated miR-204-5p expression. In conclusion, BCYRN1 acts as a promising prognostic predictor in GC patients and regulated GC cell proliferation, cell cycle, migration and invasion through targeting miR-204-5p. Introduction Gastric cancer (GC) is the fourth prevalent cancer and the second leading cause of cancer deaths world- wide [1].
    [Show full text]
  • Urb-RIP - an Adaptable and Efficient Approach for Immunoprecipitation of Rnas and Associated Rnas/Proteins Kyle A
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2016 Urb-RIP - An adaptable and efficient approach for immunoprecipitation of RNAs and associated RNAs/proteins Kyle A. Cottrell Washington University School of Medicine in St. Louis Sergej Djuranovic Washington University School of Medicine in St. Louis Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Cottrell, Kyle A. and Djuranovic, Sergej, ,"Urb-RIP - An adaptable and efficient approach for immunoprecipitation of RNAs and associated RNAs/proteins." PLoS One.11,12. e0167877. (2016). https://digitalcommons.wustl.edu/open_access_pubs/5504 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. RESEARCH ARTICLE Urb-RIP ± An Adaptable and Efficient Approach for Immunoprecipitation of RNAs and Associated RNAs/Proteins Kyle A. Cottrell, Sergej Djuranovic* Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, United States of America * [email protected] Abstract a11111 Post-transcriptional regulation of gene expression is an important process that is mediated by interactions between mRNAs and RNA binding proteins (RBP), non-coding RNAs (ncRNA) or ribonucleoproteins (RNP). Key to the study of post-transcriptional regulation of mRNAs and the function of ncRNAs such as long non-coding RNAs (lncRNAs) is an under- standing of what factors are interacting with these transcripts. While several techniques exist for the enrichment of a transcript whether it is an mRNA or an ncRNA, many of these OPEN ACCESS techniques are cumbersome or limited in their application.
    [Show full text]
  • Psychiatric Disorders and Lncrnas: a Synaptic Match
    International Journal of Molecular Sciences Review Psychiatric Disorders and lncRNAs: A Synaptic Match Francesco Rusconi *, Elena Battaglioli and Marco Venturin * Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Via Fratelli Cervi 93, 20090 Segrate, Italy; [email protected] * Correspondence: [email protected] (F.R.); [email protected] (M.V.); Tel.: +39-02-503-30445 (F.R.); +39-02-503-30443 (M.V.) Received: 23 March 2020; Accepted: 21 April 2020; Published: 25 April 2020 Abstract: Psychiatric disorders represent a heterogeneous class of multifactorial mental diseases whose origin entails a pathogenic integration of genetic and environmental influences. Incidence of these pathologies is dangerously high, as more than 20% of the Western population is affected. Despite the diverse origins of specific molecular dysfunctions, these pathologies entail disruption of fine synaptic regulation, which is fundamental to behavioral adaptation to the environment. The synapses, as functional units of cognition, represent major evolutionary targets. Consistently, fine synaptic tuning occurs at several levels, involving a novel class of molecular regulators known as long non-coding RNAs (lncRNAs). Non-coding RNAs operate mainly in mammals as epigenetic modifiers and enhancers of proteome diversity. The prominent evolutionary expansion of the gene number of lncRNAs in mammals, particularly in primates and humans, and their preferential neuronal expression does represent a driving force that enhanced the layering of synaptic control mechanisms. In the last few years, remarkable alterations of the expression of lncRNAs have been reported in psychiatric conditions such as schizophrenia, autism, and depression, suggesting unprecedented mechanistic insights into disruption of fine synaptic tuning underlying severe behavioral manifestations of psychosis.
    [Show full text]
  • Noncoding Rnas Serve As Diagnosis And
    Papers in Press. Published April 17, 2019 as doi:10.1373/clinchem.2018.301150 The latest version is at http://clinchem.aaccjnls.org/cgi/doi/10.1373/clinchem.2018.301150 Clinical Chemistry 65:7 Cancer Diagnostics 000–000 (2019) Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma Chang Tan,1,2† Jingyi Cao,1,2† Lu Chen,3,4,5† Xiaochen Xi,1 Siqi Wang,1 Yumin Zhu,1 Liuqing Yang,1 Longteng Ma,6 Dong Wang,1 Jianhua Yin,6* Ti Zhang,3,4,5* and Zhi John Lu1* BACKGROUND: Reliable noninvasive biomarkers for hep- fragment alone promoted cancer cell proliferation and atocellular carcinoma (HCC)7 diagnosis and prognosis clonogenic growth. are urgently needed. We explored the potential of not only microRNAs (miRNAs) but other types of noncod- CONCLUSIONS: Our results show that various ncRNA ing RNAs (ncRNAs) as HCC biomarkers. species, not only miRNAs, identified in the small RNA sequencing of plasma are also able to serve as noninvasive METHODS: Peripheral blood samples were collected from biomarkers. Particularly, we identified a domain of sr- 77 individuals; among them, 57 plasma cell-free RNA pRNA RN7SL1 with reliable clinical performance for transcriptomes and 20 exosomal RNA transcriptomes HCC diagnosis and prognosis. were profiled. Significantly upregulated ncRNAs and © 2019 American Association for Clinical Chemistry published potential HCC biomarkers were validated with reverse transcription (RT)-qPCR in an independent validation cohort (60–150 samples). We particularly in- vestigated the diagnosis and prognosis performance and Hepatocellular carcinoma (HCC) is the most common biological function for 1 ncRNA biomarker, RN7SL1,8 type of primary liver cancer (1).
    [Show full text]
  • Epigenetic Regulation of Alternative Splicing: How Lncrnas Tailor the Message
    non-coding RNA Review Epigenetic Regulation of Alternative Splicing: How LncRNAs Tailor the Message Giuseppina Pisignano 1,* and Michael Ladomery 2,* 1 Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK 2 Faculty of Health and Applied Sciences, University of the West of England, Coldharbour Lane, Frenchay, Bristol BS16 1QY, UK * Correspondence: [email protected] (G.P.); [email protected] (M.L.) Abstract: Alternative splicing is a highly fine-tuned regulated process and one of the main drivers of proteomic diversity across eukaryotes. The vast majority of human multi-exon genes is alternatively spliced in a cell type- and tissue-specific manner, and defects in alternative splicing can dramatically alter RNA and protein functions and lead to disease. The eukaryotic genome is also intensively transcribed into long and short non-coding RNAs which account for up to 90% of the entire tran- scriptome. Over the years, lncRNAs have received considerable attention as important players in the regulation of cellular processes including alternative splicing. In this review, we focus on recent discoveries that show how lncRNAs contribute significantly to the regulation of alternative splicing and explore how they are able to shape the expression of a diverse set of splice isoforms through several mechanisms. With the increasing number of lncRNAs being discovered and characterized, the contribution of lncRNAs to the regulation of alternative splicing is likely to grow significantly. Keywords: long non-coding RNAs; alternative splicing; splicing factors; post-transcriptional regulation Citation: Pisignano, G.; Ladomery, 1. Introduction M. Epigenetic Regulation of In the late 1970s, researchers were interested in gaining a better understanding of Alternative Splicing: How LncRNAs the mechanisms of adenoviral gene expression when they noticed something unusual, Tailor the Message.
    [Show full text]
  • Roles of Long Noncoding Rnas in Brain Development, Functional Diversification and Neurodegenerative Diseases
    Brain Research Bulletin 97 (2013) 69–80 Contents lists available at ScienceDirect Brain Research Bulletin jo urnal homepage: www.elsevier.com/locate/brainresbull Review Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases 1 1 ∗ Ping Wu , Xialin Zuo , Houliang Deng, Xiaoxia Liu, Li Liu, Aimin Ji Center for Drug Research and Development, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, PR China a r t i c l e i n f o a b s t r a c t Article history: Long noncoding RNAs (lncRNAs) have been attracting immense research interest, while only a handful of Received 25 February 2013 lncRNAs have been characterized thoroughly. Their involvement in the fundamental cellular processes Received in revised form 31 May 2013 including regulate gene expression at epigenetics, transcription, and post-transcription highlighted a cen- Accepted 1 June 2013 tral role in cell homeostasis. However, lncRNAs studies are still at a relatively early stage, their definition, Available online 10 June 2013 conservation, functions, and action mechanisms remain fairly complicated. Here, we give a systematic and comprehensive summary of the existing knowledge of lncRNAs in order to provide a better under- Keywords: standing of this new studying field. lncRNAs play important roles in brain development, neuron function Expression signature lncRNA and maintenance, and neurodegenerative diseases are becoming increasingly evident. In this review, we also highlighted recent studies related lncRNAs in central nervous system (CNS) development and Noncoding RNA Neuron neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s Neurodegenerative disease disease (HD) and amyotrophic lateral sclerosis (ALS), and elucidated some specific lncRNAs which may be important for understanding the pathophysiology of neurodegenerative diseases, also have the potential as therapeutic targets.
    [Show full text]
  • General and Target-Specific Dexd/H RNA Helicases in Eukaryotic Translation Initiation
    International Journal of Molecular Sciences Review General and Target-Specific DExD/H RNA Helicases in Eukaryotic Translation Initiation Leo Shen 1 and Jerry Pelletier 1,2,3,* 1 Department of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada; [email protected] 2 Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada 3 Rosalind and Morris Goodman Cancer Research Center, McGill University, Montreal, QC H3A 1A3, Canada * Correspondence: [email protected]; Tel.: +1-514-398-2323 Received: 5 June 2020; Accepted: 18 June 2020; Published: 20 June 2020 Abstract: DExD (DDX)- and DExH (DHX)-box RNA helicases, named after their Asp-Glu-x-Asp/His motifs, are integral to almost all RNA metabolic processes in eukaryotic cells. They play myriad roles in processes ranging from transcription and mRNA-protein complex remodeling, to RNA decay and translation. This last facet, translation, is an intricate process that involves DDX/DHX helicases and presents a regulatory node that is highly targetable. Studies aimed at better understanding this family of conserved proteins have revealed insights into their structures, catalytic mechanisms, and biological roles. They have also led to the development of chemical modulators that seek to exploit their essential roles in diseases. Herein, we review the most recent insights on several general and target-specific DDX/DHX helicases in eukaryotic translation initiation. Keywords: helicase; translation; initiation; DDX; DHX; eIF4A1; DDX3X; DHX9; DHX29; DHX36 1. Introduction RNA helicases play a role in all facets of RNA metabolism, ranging from transcription and translation, to processing and decay. These highly conserved enzymes use ATP to bind, unwind, and disrupt RNA structures and RNA-protein complexes [1].
    [Show full text]
  • Long Non-Coding Rnas As Functional Codes for Oral Cancer: Translational Potential, Progress and Promises
    International Journal of Molecular Sciences Review Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises Cing-Syuan Lei 1, Hsing-Jien Kung 1,2,3,4,5 and Jing-Wen Shih 1,2,5,6,* 1 Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; [email protected] (C.-S.L.); [email protected] (H.-J.K.) 2 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan 3 Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan 4 Comprehensive Cancer Center, Department of Biochemistry and Molecular Medicine, University of California at Davis, Sacramento, CA 95817, USA 5 TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan 6 Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan * Correspondence: [email protected] Abstract: Oral cancer is one of the leading malignant tumors worldwide. Despite the advent of multidisciplinary approaches, the overall prognosis of patients with oral cancer is poor, mainly due to late diagnosis. There is an urgent need to develop valid biomarkers for early detection and effective therapies. Long non-coding RNAs (lncRNAs) are recognized as key elements of gene regulation, with pivotal roles in various physiological and pathological processes, including cancer. Over the past few years, an exponentially growing number of lncRNAs have been identified and linked to Citation: Lei, C.-S.; Kung, H.-J.; Shih, J.-W.
    [Show full text]
  • The Rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson's Disease in the Hungarian Population
    Hindawi Parkinson’s Disease Volume 2018, Article ID 9351598, 7 pages https://doi.org/10.1155/2018/9351598 Research Article The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson’s Disease in the Hungarian Population Sa´ndor Ma´rki ,1 Aniko´ Go¨blo¨s ,2,3 Eszter Szla´vicz,2 No´ra To¨ro¨k ,4 Pe´ter Balicza,5 Benjamin Bereznai,5 Annama´ria Taka´ts,6 Jo´zsef Engelhardt,4 Pe´ter Klive´nyi ,4 La´szlo´ Ve´csei ,4,7 Ma´ria Judit Molna´r,5 Nikoletta Nagy ,1 and Ma´rta Sze´ll1,3 1Department of Medical Genetics, University of Szeged, Somogyi u. 4, 6720 Szeged, Hungary 2Department of Dermatology and Allergology, University of Szeged, Kora´nyi fasor 6, 6720 Szeged, Hungary 3MTA-SZTE Dermatological Research Group, University of Szeged, Kora´nyi fasor 6, 6720 Szeged, Hungary 4Department of Neurology, University of Szeged, Semmelweis u. 6, 6725 Szeged, Hungary 5Institute of Genomic Medicine and Rare Disorders, Semmelweis University, T¨omő u. 25-29, 1083 Budapest, Hungary 6Department of Neurology, Semmelweis University, VIII. Balassa J. u. 6, 1083 Budapest, Hungary 7MTA-SZTE Neuroscience Research Group, University of Szeged, Semmelweis u. 6, 6725 Szeged, Hungary Correspondence should be addressed to Aniko´ Go¨blo¨s; [email protected] Received 18 December 2017; Accepted 12 March 2018; Published 3 April 2018 Academic Editor: Ivan Bodis-Wollner Copyright © 2018 Sa´ndor Ma´rki et al. .is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]